OxyContin maker Purdue Pharma LP is struggling with slumping sales, a shrinking workforce and restructuring challenges as it battles lawsuits related to the opioid crisis, the Wall Street Journal reported. Purdue’s revenue is expected to drop below $1 billion this year for the first time in more than a decade, as employees leave and a potential bankruptcy filing looms. Controlled by members of the billionaire Sackler family, Purdue has also been reviewing the corporate structure of at least two dozen entities affiliated with the company that are under government scrutiny for possible fraud. Purdue has previously said that it may file for bankruptcy but hasn’t made a decision.
